arcoro CONNECT

Smart drug discovery

Artificial intelligence is increasingly establishing itself in the pharmaceutical industry. Research into new or optimizable active ingredients for drug production and disease control is an essential area in the industry. The combination of the permanently growing number of possible active ingredient candidates simultaneously requires a huge amount of data. In order to keep track of this number and derive the right conclusions, artificial intelligence is increasingly being called upon to provide information about the most important changes and developments. Artificial intelligence also helps to include all available data, since according to recent studies, 80 percent of medical data is not used after it has been collected.

Read our new arcoro CONNECT to learn more about mergers between different pharmaceutical and IT companies and how AI can efficiently support drug discovery.

Facts at a glance

Did you know that only 10 percent of potential drug candidates make it to market after Phase 1 trials? Or did you know that it costs around $2.6 billion to bring a new compound to market today? Drug discovery is a lengthy and costly process for companies, which is why the use of AI in research promises great success.

Your contact person

Anne Plonz

Business Analyst

Phone: +4915156319362

Email: plonz@arcoro.de

Field of expertise

We connect people with opportunities and knowledge

We are here for you! Whether project inquiries, market information or the desire for an active cooperation. We have a sympathetic ear for your concerns and are sure we can help quickly.

    * Requiered fields
    Your contact person

    Anne Plonz

    Business Analyst

    Phone: +4915156319362

    Email: plonz@arcoro.de